Cork, Ireland – April 3, 2012 - QUMAS today announced that Weifa, a leading pharmaceutical company based in Norway, has selected QUMAS ComplianceSP on Microsoft SharePoint 2010 to manage regulatory documents and quality processes across the organization.
In selecting QUMAS, Weifa will implement an electronic quality management system to maintain compliance with the pharmaceutical "current Good Manufacturing Practices" (cGMP) standards, and will reduce the number of separate and non-interrelated systems required to fulfill those needs.
QUMAS ComplianceSP will be deployed to a broad range of users to enable them to control quality and manufacturing documents such as standard operating procedures, policies and manuals; to create, authorize, review, and approve structured documents with metadata; and to support quality processes such as CAPA, Deviation, Change Control, Audit Management, and Training/Learning Management.
QUMAS ComplianceSP is an innovative compliance management platform that combines the power of Microsoft SharePoint 2010 with the proven regulatory domain expertise that QUMAS has gained from almost two decades of providing solutions to regulated industries. Combined with a best practice approach for managing documents, processes, people and tasks, ComplianceSP on SharePoint 2010 delivers a unique solution that can manage a wide range of compliance activities on the latest technologies.
"We were looking for a vendor with a demonstrated track record for delivery to the pharmaceutical/biotech industry," stated Lilly Margareth Myhra, Director of Quality Management & QC at Weifa. "We have an aggressive roll out schedule, so the time required for implementation and training was an important factor in the selection process. QUMAS came out the clear leader in all of our selection criteria, also providing the track record and the strategic commitment to SharePoint that we were looking for."
"ComplianceSP provides Weifa with a complete quality management solution that leverages all the benefits of SharePoint 2010 and additional Microsoft technologies including Office, Outlook, and InfoPath," said Kevin O'Leary, CEO for QUMAS. "By using familiar Microsoft technologies, we are able to provide companies with a solution that increases business productivity, simplifies end-user training, reduces internal support requirements, and greatly reduces compliance risk."
Weifa is a Norwegian based pharmaceutical company active throughout the value chain - from research and development to production, distribution and sales. Their vision is to be the most trusted and valued Nordic supplier of products and solutions in the fields of medicines and lifestyle products. They produce active pharmaceutical ingredients and about 100 different finished pharmaceutical products. The company currently sells products all over the world with their main finished dosage market in Nordic countries. For more information, visit www.weifa.no/.
QUMAS is the leader in Compliance and Quality Management Solutions for the Life Sciences industry, with more than 260 global customer deployments and domain expertise in regulatory compliance since 1994.
QUMAS Quality Management solutions provide Electronic Document Management (SOPs, QA documents), Electronic Process Management (CAPA, Deviation, Change Control, Audit), and GMP Compliance Management. QUMAS Regulatory Affairs solutions provide content and Submission Management including eCTD authoring templates, collaborative review, full integration with leading publishing solutions, scanning, and automated import of paper documents.